🇺🇸 FDA
Pipeline program

Olfactory ensheathing cells

CN1U00-1

Phase 1 other active

Quick answer

Olfactory ensheathing cells for Infarction, Middle Cerebral Artery is a Phase 1 program (other) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).

Program details

Company
China SXT Pharmaceuticals
Indication
Infarction, Middle Cerebral Artery
Phase
Phase 1
Modality
other
Status
active

Clinical trials